Trademark: 97844109
Word
CYTOSORB THERAPY REGAIN CONTROL
Status Date
Tuesday, January 30, 2024
Filing Date
Friday, March 17, 2023
Published for Opposition
Tuesday, December 5, 2023
10 Medical devices, namely, adsorption and absorption materials and systems for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome SIRS, sepsis and infection, other immunologic conditions, or organ dysfunction or failure
Jan 30, 2024
Noa E-Mailed - Sou Required From Applicant
Dec 5, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Published For Opposition
Nov 15, 2023
Notification Of Notice Of Publication E-Mailed
Nov 1, 2023
Approved For Pub - Principal Register
Oct 25, 2023
Teas/Email Correspondence Entered
Oct 24, 2023
Correspondence Received In Law Office
Oct 24, 2023
Teas Response To Office Action Received
Aug 14, 2023
Notification Of Non-Final Action E-Mailed
Aug 14, 2023
Non-Final Action E-Mailed
Aug 14, 2023
Non-Final Action Written
Aug 8, 2023
Assigned To Examiner
Apr 9, 2023
New Application Office Supplied Data Entered
Mar 21, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
